3D printing/additive technology is exploding beyond the bounds of industrial applications. Building on the realization that a cell is roughly the same size as a drop of ink, dozens of university biomedical researchers and labs are now applying the grid–based, layer–by–layer “additive†method using adapted printer cartridge heads. The technique is already being used to create tissue scaffolds and lattices, replacement tissues, and ultimately complete organs from stem cells. Some applications, like using 3D printed tissues for in vitro toxicology testing and surgical training, could be nearer term. The implications for drug–testing, life extension, surgical cosmetics and life threatening conditions are revolutionary.<br>However, this field is advancing so rapidly and on so many fronts that only those who are current on today’s development will successfully realize the enormous promise of this technology.<br>To accelerate commercialization of this highly innovative field, Infocast is organizing the first dedicated Bio–Printing Summit, November 13–14, 2013 in Atlanta, GA. This event will bring together the leading global researchers from the tissue engineering, bioengineering and biomedical communities to meet for the first time with vendors and developers of 3D printing technology (printers, CAD software, biocompatible materials), health care/life science venture investors, biomedical device companies, toxicologists from drug and chemical companies, hospital R&D directors, and analysts to build relationships and explore licensing, investment, commercialization strategies and timelines. The Summit will showcase advanced applications in combining tissues with complex geometry, biocompatible materials, tissues made up of multiple cell types or cellular ecosystems, ultimately moving towards the goal of complete, individually tailored organ printing.<br>
Abbrevation
Bio-Printing
City
Atlanta
Country
United States
Deadline Paper
Start Date
End Date
Abstract